Rituximab levels are associated with the B cell homeostasis but not with the clinical response in patients with rheumatoid arthritis

OBJECTIVE: To study the levels of rituximab (RTX) and anti-RTX antibodies (ARAs) in patients with rheumatoid arthritis (RA) at 30, 90, and 180 days after the first infusion, in relation to clinical and serological parameters and B cell homeostasis. METHODS: Thirty-four patients with RA who failed to...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eur J Rheumatol
Hlavní autoři: Díaz-Torné, Cèsar, Ortiz, Maria Àngels, Sarmiento, Mónica, Díaz-López, César, Corominas, Hèctor, Casademont, Jordi, Vidal, Silvia
Médium: Artigo
Jazyk:Inglês
Vydáno: Medical Research and Education Association 2019
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6467324/
https://ncbi.nlm.nih.gov/pubmed/31365341
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurjrheum.2019.18109
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky